A phase I study of palliative chemoradiation therapy with paclitaxel and cisplatin for local symptoms due to an unresectable primary advanced or locally recurrent gastric adenocarcinoma

Cancer Chemotherapy and Pharmacology

Volumn 64, Issue 6, 2009, Pages 1071-1077

  Yoshikawa, Takaki ^a   Tsuburaya, Akira ^a   Hirabayashi, Naoki ^b   Yoshida, Kazuhiro ^c   Nagata, Naoki ^d   Kodera, Yasuhiro ^e   Takahashi, Naoto ^f   Oba, Koji ^g   Kimura, Masayuki ^h   Ishikura, Satoshi ⁱ   Miyashita, Yumi ^j   Sakamoto, Junichi ^e  

^a KANAGAWA CANCER CENTER   (Japan)

^b HIROSHIMA CITY ASA HOSPITAL   (Japan)

^c GIFU UNIVERSITY   (Japan)

^d UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^e NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^h ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁱ NATIONAL CANCER CENTER   (Japan)

^j Nonprofit Organization ECRIN   (Japan)

more..

Author keywords

Chemoradiation; Gastric cancer; Local recurrence; Palliation; Phase I study

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; C REACTIVE PROTEIN; CISPLATIN; CREATININE; PACLITAXEL;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANOREXIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CREATININE BLOOD LEVEL; DRUG DOSE ESCALATION; DRUG TOLERABILITY; ESOPHAGITIS; FATIGUE; FEMALE; FEVER; GASTROINTESTINAL OBSTRUCTION; GASTROINTESTINAL PAIN; HUMAN; HYPONATREMIA; MALE; MAXIMUM TOLERATED DOSE; MULTIPLE CYCLE TREATMENT; NAUSEA; PHASE 1 CLINICAL TRIAL; PNEUMONIA; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; RECURRENT CANCER; SIDE EFFECT; STOMACH ADENOCARCINOMA; SYMPTOMATOLOGY; THROMBOCYTOPENIA; TREATMENT RESPONSE; VOMITING;

ADENOCARCINOMA; AGED; CISPLATIN; FEMALE; HUMANS; MALE; MAXIMUM TOLERATED DOSE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PACLITAXEL; PALLIATIVE CARE; RADIOTHERAPY; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 69049117212     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-009-0963-3     Document Type: Article

References (20)

1. DM Roder 2002 The epidemiology of gastric cancer Gastric Cancer 5 5 11
2. M Sasako 2003 Principles of surgical treatment for curable gastric cancer J Clin Oncol 21 23 Suppl 274 275
3. A Ohtsu S Yoshida N Saijo 2006 Disparities in gastric cancer chemotherapy between the east and west J Clin Oncol 24 2188 2196
4. Boku N, Yamamoto S, Shirao K, Doi T, Sawaki A, Koizumi W et al (2007) Randomized phase III study of 5-fluorouracil (5-FU) alone versus combination of irinotecan and cisplatin (CP) versus S-1 alone in advanced gastric cancer (JCOG9912). In: The 43rd annual meeting of American Society of Clinical Oncology, Chicago, IL, 1-5 Jun 2007, abstr LBA4513
5. W Koizumi H Narahara T Hara A Takagane A Akiya M Takagi, et al. 2008 S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial Lancet Oncol 9 215 221
6. JS Macdonald SR Smalley J Benedetti SA Hundahl NC Estes GN Stemmermann, et al. 2001 Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction N Engl J Med 345 725 730
7. H Safran HJ Wanebo PJ Hesketh P Akerman D Ianitti W Cioffi, et al. 2000 Paclitaxel and concurrent radiation for gastric cancer Int J Radiat Oncol Biol Phys 46 889 894
8. JA Ajani PF Mansfield N Janjan J Morris PW Pisters PM Lynch, et al. 2004 Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma J Clin Oncol 22 2774 2780
9. JA Ajani PF Mansfield CH Crane TT Wu S Lunagomez PM Lynch, et al. 2005 Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcome J Clin Oncol 23 1237 1244
10. JA Ajani K Winter GS Okawara JH Donohue PW Pisters CH Crane, et al. 2006 Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response J Clin Oncol 24 3953 3958
11. Japanese translation of common terminology criteria for adverse events (CTCAE), and instructions and guidelines (2004). Int J Clin Oncol Suppl 3:1-82
12. J Landry JE Tepper WC Wood EO Moulton F Koerner J Sullinger 1990 Patterns of failure following curative resection of gastric cancer Int J Radiat Oncol Biol Phys 191 1357 1362
13. JJ Bonenkamp I Songun J Hermans M Sasako K Welvaar JT Plukker, et al. 1995 Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients Lancet 345 745 748
14. JJ Bonenkamp I Songun J Hermans M Sasako K Welvaar JT Plukker, et al. 1999 Extended lymph-node dissection for gastric cancer N Engl J Med 340 908 914
15. A Cuschieri P Fayers J Fielding J Craven J Bancewicz V Joypaul, et al. 1996 Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial-The Surgical Cooperative Group Lancet 347 995 999
16. A Cuschieri S Weeden J Fielding J Bancewicz J Craven V Joypaul, et al. 1999 Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial Br J Cancer 79 1522 1530
17. T Sano M Sasako S Yamamoto A Nashimoto A Kurita M Hiratsuka, et al. 2004 Morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy-Japan Clinical Oncology Group Study 9501 J Clin Oncol 22 2767 2773
18. M Sasako T Sano S Yamamoto A Nashimoto A Kurita H Furukawa, et al. 2006 Randomized phase III trial of standard D2 versus D2 + para-aortic lymph node (PAN) dissection (D) for clinically M0 advanced gastric cancer: JCOG9501 J Clin Oncol 24 182s
19. CW Wu CA Hsiung SS Lo MC Hsieh JH Chen AF Li, et al. 2006 Nodal dissection for patients with gastric cancer: a randomised controlled trial Lancet Oncol 7 309 315
20. N Nagata M Kobayashi H Kojima K Kondo N Hirabayashi T Matsui, et al. 2005 Phase I study of paclitaxel and cisplatin for patients with advanced or recurrent gastric cancer Hepatogastroenterology 52 1905 1910